These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12737535)

  • 1. Preparation and characterization of chitosan microspheres containing doxifluridine.
    Yoshino T; Machida Y; Onishi H; Nagai T
    Drug Dev Ind Pharm; 2003 Apr; 29(4):417-27. PubMed ID: 12737535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The serum and tissue concentration of FT-207, 5'-DFUR and 5-FU in patients with breast cancer by preoperative administration of UFT and 5'-DFUR].
    Kosaka A; Sumiyoshi K; Ando J
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):277-80. PubMed ID: 2521996
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of pharmacokinetics of 5-FU and alpha-fluoro-beta-alanine, a metabolite of 5-FU, in plasma after administration of UFT, tegafur, 5-FU or doxifluridine to rats].
    Kuwata K; Nagayama S; Hirakawa Y; Matsushima E; Kawaguchi Y
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):885-90. PubMed ID: 10897216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics.
    Akbuğa J; Bergişadi N
    J Microencapsul; 1996; 13(2):161-8. PubMed ID: 8999121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of coadministered uridine on intestinal first-pass metabolism of 5'-deoxy-5-fluorouridine in conscious rats--an evaluation by method of portal-systemic concentration difference.
    Sawai Y; Yamaoka K; Nakagawa T
    Pharm Res; 1998 Jul; 15(7):1007-11. PubMed ID: 9688052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosolic and microsomal activation of doxifluridine and tegafur to produce 5-fluorouracil in human liver.
    Ozawa S; Hamada M; Murayama N; Nakajima Y; Kaniwa N; Matsumoto Y; Fukuoka M; Sawada J; Ohno Y
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):454-8. PubMed ID: 12451471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of capecitabine and its three nucleoside metabolites in human plasma by high performance liquid chromatography-tandem mass spectrometry.
    Deng P; Ji C; Dai X; Zhong D; Ding L; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 989():71-9. PubMed ID: 25808944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours.
    Chandy T; Das GS; Rao GH
    J Microencapsul; 2000; 17(5):625-38. PubMed ID: 11038121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.
    Menei P; Boisdron-Celle M; Croué A; Guy G; Benoit JP
    Neurosurgery; 1996 Jul; 39(1):117-23; discussion 123-4. PubMed ID: 8805147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Fluorouracil concentration in blood, liver and tumor tissues and apoptosis of tumor cells after preoperative oral 5'-deoxy-5-fluorouridine in patients with hepatocellular carcinoma.
    Zheng JF; Wang HD
    World J Gastroenterol; 2005 Jul; 11(25):3944-7. PubMed ID: 15991299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and properties of 5-fluorouracil-loaded chitosan microspheres for the intranasal administration].
    Zheng AP; Yu SY; Zhao Y; Wu FL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):300-4. PubMed ID: 15205705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eudragit-coated dextran microspheres of 5-fluorouracil for site-specific delivery to colon.
    Rai G; Yadav AK; Jain NK; Agrawal GP
    Drug Deliv; 2016; 23(1):328-37. PubMed ID: 24845476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate loaded chitosan and chitin microspheres--in vitro characterization and pharmacokinetics in mice bearing Ehrlich ascites carcinoma.
    Singh UV; Udupa N
    J Microencapsul; 1998; 15(5):581-94. PubMed ID: 9743914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [5-FU concentrations in the blood and tumor tissue after 5'-DFUR or UFT administration in the patients with uterine cervical cancer].
    Suzuki M; Aida I; Ohwada M; Sato I; Tamura T; Kasuga Y
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):253-8. PubMed ID: 7857101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression of phenytoin metabolic capacity by 5-fluorouracil and doxifluridine in rats.
    Konishi H; Yoshimoto T; Morita K; Minouchi T; Sato T; Yamaji A
    J Pharm Pharmacol; 2003 Jan; 55(1):143-9. PubMed ID: 12625878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5'-deoxy-5-fluorouridine against adenocarcinoma 755 in mice. Correlation with pharmacokinetics of plasma 5-fluorouracil levels.
    Iigo M; Nishikata K; Nakajima Y; Hoshi A; Okudaira N; Odagiri H; De Clercq E
    Biochem Pharmacol; 1989 Jun; 38(12):1885-9. PubMed ID: 2525905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reacetylated chitosan microspheres for controlled delivery of anti-microbial agents to the gastric mucosa.
    Portero A; Remuñán-López C; Criado MT; Alonso MJ
    J Microencapsul; 2002; 19(6):797-809. PubMed ID: 12569028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of acyclothymidine, a potent pyrimidine nucleoside phosphorylase inhibitor, on the pharmacokinetics of doxifluridine in rabbits via oral administration.
    Hamada A; Fukushima S; Morinaga A; Saneyoshi M; Kawaguchi T; Nakano M
    Biol Pharm Bull; 1993 Dec; 16(12):1297-300. PubMed ID: 8130783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of 5-Fluorouracil loaded chitosan microspheres by a two-step solidification method.
    Sun Y; Gu L; Gao Y; Gao F
    Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):891-5. PubMed ID: 20606332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone.
    al-Helw AA; Al-Angary AA; Mahrous GM; al-Dardari MM
    J Microencapsul; 1998; 15(3):373-82. PubMed ID: 9608399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.